Showing results (11-20 of 16) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
British Journal of Haematology|May 22, 2008
The novel bispecific diabody alphaCD40/alphaCD28 strengthens leukaemic dendritic cell-induced T-cell reactivityIlse Houtenbos, Saskia Santegoets, Theresia M Westers, et al.European Journal of Clinical Pharmacology|July 28, 2021
Unintentional guideline deviations in hospitalized patients with two or more antithrombotic agents: an intervention studyRenate C A E van Uden, Marcel P H van den Broek, Ilse Houtenbos, et al.Journal of Extracellular Vesicles|March 26, 2026
Small and Large Extracellular Vesicles in Circulation of Diffuse Large B-Cell Lymphoma Patients Originate From Different Cell Types of the Tumor MicroenvironmentFilippo Maltoni, Steven Wang, Mischa F B Steketee, et al.The Lancet. Haematology|March 3, 2022
Venetoclax consolidation after fixed-duration venetoclax plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (HOVON 139/GiVe): primary endpoint analysis of a multicentre, open-label, randomised, parallel-group, phase 2 trialSabina Kersting, Julie Dubois, Kazem Nasserinejad, et al.The Lancet. Oncology|December 16, 2019
Role of eHealth application Oncokompas in supporting self-management of symptoms and health-related quality of life in cancer survivors: a randomised, controlled trialAnja van der Hout, Cornelia F van Uden-Kraan, Karen Holtmaat, et al.Blood|June 26, 2023
Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLLLina van der Straten, Claudia A M Stege, Sabina Kersting, et al.Pageof 2